Cosmo Chemical Co., Ltd.

KRX:005420.KS

21750 (KRW) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 798,983.653718,194.57512,614.348355,501.971406,823.04678,093.566431,646.98286,513.279250,018.823281,848.632315,361.574309,164.19172,362.821124,716.324110,563.824103,633.42986,532.949
Cost of Revenue 754,413.96637,449.553448,345.64320,554.873382,710.862641,968.559382,993.015271,804.667262,665.654289,179.231298,592.735283,133.053130,294.93699,730.32189,773.08693,830.59289,501.656
Gross Profit 44,569.69380,745.01764,268.70934,947.09824,112.17836,125.00748,653.96514,708.612-12,646.832-7,330.59816,768.83826,031.13742,067.88424,986.00320,790.7379,802.837-2,968.707
Gross Profit Ratio 0.0560.1120.1250.0980.0590.0530.1130.051-0.051-0.0260.0530.0840.2440.20.1880.095-0.034
Reseach & Development Expenses 3,776.353,455.8333,332.8393,861.5113,825.8973,088.4273,083.18888.163174.01356.165256.217206.31154.49493.02698.61396.935371.978
General & Administrative Expenses 3,497.9493,294.3932,701.0052,446.9312,990.5212,782.6531,984.3691,894.9672,014.3832,758.52,984.53,686.7272,221.1032,025.8931,430.7691,379.4281,852.844
Selling & Marketing Expenses 14,812.14913,328.57411,019.3997,583.5348,109.94911,255.83111,585.04111,562.79712,189.47413,162.99315,497.12615,226.94511,677.75711,985.9478,659.9076,304.2633,993.357
SG&A 36,997.00716,622.96713,720.40410,030.46511,100.4714,038.48313,569.4113,457.76414,203.85715,921.49318,481.62718,913.67213,898.8614,011.8410,090.6767,683.6915,846.201
Other Expenses -880.50919,238.29316,731.64715,924.43514,408.555-3,937.782-7,636.814-11,114.9978,436.738325.5051,184.4923,639.966708.4614,714.092,959.4042,438.841,831.818
Operating Expenses 41,653.86639,317.09333,784.8929,816.41129,334.92229,170.84727,978.39628,689.13326,601.0728,813.4530,822.30331,121.13120,865.44418,818.95613,148.69312,179.10110,133.645
Operating Income 2,915.82741,427.92330,483.8195,000.687-10,897.6986,248.4220,675.569-13,980.521-39,247.902-36,144.049-14,053.465-5,089.99421,202.445,914.6866,444.826-2,376.263-13,102.352
Operating Income Ratio 0.0040.0580.0590.014-0.0270.0090.048-0.049-0.157-0.128-0.045-0.0160.1230.0470.058-0.023-0.151
Total Other Income Expenses Net -8,879.206-5,413.804-1,985.212-23,846.449-7,844.661-15,655.6573,731.225-58,528.021-83,251.718-20,284.4658,919.336-21,228.261-7,192.68524,742.381-5,426.46-3,369.273-4,454.997
Income Before Tax -5,963.37936,014.11928,498.607-18,845.762-18,742.359-8,701.49824,406.794-72,508.542-122,499.62-56,428.514-5,134.129-26,318.25414,009.75630,909.4292,215.585-5,745.537-17,557.349
Income Before Tax Ratio -0.0070.050.056-0.053-0.046-0.0130.057-0.253-0.49-0.2-0.016-0.0850.0810.2480.02-0.055-0.203
Income Tax Expense 598.3184,542.4484,995.446-3,224.857-4,196.542137.543-2,930.048-16,623.78-614.353-9,025.757642.731-12,193.7932,108.11532,021.096389.092-875.2611,077.629
Net Income -26,827.30931,471.67123,503.161-15,620.904-14,545.817-15,893.6221,441.409-73,354.028-106,858.726-42,250.228-522.868-17,648.88814,009.75630,909.4292,215.585-5,745.537-17,557.349
Net Income Ratio -0.0340.0440.046-0.044-0.036-0.0230.05-0.256-0.427-0.15-0.002-0.0570.0810.2480.02-0.055-0.203
EPS -753.82918.19736.47-513.83-635.28-745.261,167.79-4,278.47-6,265.08-2,454.87-30.39-1,025.71886.672,143.35153.48-398.13-1,224.01
EPS Diluted -753.82918.19736.47-513.83-635.28-745.261,078.14-4,189.46-6,135.26-2,454.87-30.39-1,025.71812.972,143.35153.48-398.13-1,224.01
EBITDA 26,245.20868,816.9658,918.13627,000.8959,848.39517,818.91850,257.324-13,288.538-15,356.314-3,722.0614,332.88216,189.54636,755.1449,357.41918,962.1427,553.243184.962
EBITDA Ratio 0.0330.0960.1150.0760.0240.0260.116-0.046-0.061-0.0130.0450.0520.2130.3960.1720.0730.002